Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection? 1996

E Apartis, and J M Léger, and L Musset, and M Gugenheim, and P Cacoub, and O Lyon-Caen, and C Pierrot-Deseilligny, and J J Hauw, and P Bouche
Department of Neurology, Hôpital Pitié-Salpêtrière, Paris, France.

BACKGROUND The prevalence of hepatitis C virus (HCV) infection has been estimated at 43 to 84% in patients with essential mixed cryoglobulinaemia in recent large series. Some of these cases have been successfully treated with interferon-alpha. The objective was to evaluate the prevalence and the possible role of HCV infection in essential mixed cryoglobulinaemia. METHODS Fifteen patients (eight men and seven women; mean age: 61.2 (SD 16.5) years) with peripheral neuropathy (10 polyneuropathies and five multifocal mononeuropathies) and essential mixed cryoglobulinaemia were tested for serum anti-HCV antibodies. RESULTS Antibodies were found in 10 of 15 patients involving either polyneuropathies (seven patients) or multifocal mononeuropathies (three patients). Electrophysiological studies and teased nerve fibre studies (in seven patients) allowed neuropathies to be classified as predominantly sensory axonopathies. Compared with HCV-negative (HCV -) patients, HCV-positive (HCV +) patients had a more pronounced and more widespread motor deficit; motor nerve conduction velocities in peroneal and median nerves were more impaired in HCV + patients, although significance was not reached except for the mean value of the amplitude of the compound muscle action potentials of the median nerves (P < 0.05); necrotising vasculitis was found in two of nine nerve biopsies from the HCV + patients studied and in none of the three HCV - patients. In addition, HCV + patients had more frequent cryoglobulin related cutaneous signs, higher aminotransferase and serum cryoglobulin concentrations, lower total haemolytic complement concentrations, and more frequent presence of rheumatoid factor. A liver biopsy performed in eight HCV + patients disclosed a range of lesions, from chronic active hepatitis (six patients) to persistent hepatitis (two patients). Lastly, treatment with interferon-alpha conducted over six months in two patients seemed to improve the peripheral neuropathy. CONCLUSIONS Patients with peripheral neuropathy and essential mixed cryoglobulinaemia should be tested for anti-HCV antibodies to determine the appropriate treatment.

UI MeSH Term Description Entries
D008297 Male Males
D008475 Median Nerve A major nerve of the upper extremity. In humans, the fibers of the median nerve originate in the lower cervical and upper thoracic spinal cord (usually C6 to T1), travel via the brachial plexus, and supply sensory and motor innervation to parts of the forearm and hand. Median Nerves,Nerve, Median,Nerves, Median
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009431 Neural Conduction The propagation of the NERVE IMPULSE along the nerve away from the site of an excitation stimulus. Nerve Conduction,Conduction, Nerve,Conduction, Neural,Conductions, Nerve,Conductions, Neural,Nerve Conductions,Neural Conductions
D010523 Peripheral Nervous System Diseases Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves. Peripheral Nerve Diseases,Peripheral Neuropathies,PNS (Peripheral Nervous System) Diseases,PNS Diseases,Peripheral Nervous System Disease,Peripheral Nervous System Disorders,Nerve Disease, Peripheral,Nerve Diseases, Peripheral,Neuropathy, Peripheral,PNS Disease,Peripheral Nerve Disease,Peripheral Neuropathy
D010543 Peroneal Nerve The lateral of the two terminal branches of the sciatic nerve. The peroneal (or fibular) nerve provides motor and sensory innervation to parts of the leg and foot. Fibular Nerve,Fibular Nerves,Nerve, Fibular,Nerve, Peroneal,Nerves, Fibular,Nerves, Peroneal,Peroneal Nerves
D003449 Cryoglobulinemia A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas. Cryoglobulinemias
D003450 Cryoglobulins Abnormal immunoglobulins, especially IGG or IGM, that precipitate spontaneously when SERUM is cooled below 37 degrees Celsius. It is characteristic of CRYOGLOBULINEMIA. Cryoglobulin,Cryoprotein,Cryoproteins
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females

Related Publications

E Apartis, and J M Léger, and L Musset, and M Gugenheim, and P Cacoub, and O Lyon-Caen, and C Pierrot-Deseilligny, and J J Hauw, and P Bouche
March 2001, Annals of the rheumatic diseases,
E Apartis, and J M Léger, and L Musset, and M Gugenheim, and P Cacoub, and O Lyon-Caen, and C Pierrot-Deseilligny, and J J Hauw, and P Bouche
September 2003, Journal of neurology, neurosurgery, and psychiatry,
E Apartis, and J M Léger, and L Musset, and M Gugenheim, and P Cacoub, and O Lyon-Caen, and C Pierrot-Deseilligny, and J J Hauw, and P Bouche
August 1993, British journal of rheumatology,
E Apartis, and J M Léger, and L Musset, and M Gugenheim, and P Cacoub, and O Lyon-Caen, and C Pierrot-Deseilligny, and J J Hauw, and P Bouche
January 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
E Apartis, and J M Léger, and L Musset, and M Gugenheim, and P Cacoub, and O Lyon-Caen, and C Pierrot-Deseilligny, and J J Hauw, and P Bouche
June 1994, British journal of rheumatology,
E Apartis, and J M Léger, and L Musset, and M Gugenheim, and P Cacoub, and O Lyon-Caen, and C Pierrot-Deseilligny, and J J Hauw, and P Bouche
February 1992, Journal of neurology, neurosurgery, and psychiatry,
E Apartis, and J M Léger, and L Musset, and M Gugenheim, and P Cacoub, and O Lyon-Caen, and C Pierrot-Deseilligny, and J J Hauw, and P Bouche
November 1997, European journal of gastroenterology & hepatology,
E Apartis, and J M Léger, and L Musset, and M Gugenheim, and P Cacoub, and O Lyon-Caen, and C Pierrot-Deseilligny, and J J Hauw, and P Bouche
August 1995, Scandinavian journal of immunology,
E Apartis, and J M Léger, and L Musset, and M Gugenheim, and P Cacoub, and O Lyon-Caen, and C Pierrot-Deseilligny, and J J Hauw, and P Bouche
February 1997, The British journal of dermatology,
E Apartis, and J M Léger, and L Musset, and M Gugenheim, and P Cacoub, and O Lyon-Caen, and C Pierrot-Deseilligny, and J J Hauw, and P Bouche
December 1997, Italian journal of gastroenterology and hepatology,
Copied contents to your clipboard!